Skip to main content
. Author manuscript; available in PMC: 2011 Aug 25.
Published in final edited form as: Nucl Med Biol. 2009 Feb;36(2):215–223. doi: 10.1016/j.nucmedbio.2008.11.010

Figure 3.

Figure 3

(a) TAC’s of plasma from two baseline studies for the first two minutes. (b) Area under the curve (AUC) of [11C-cyano]letrozole concentration in plasma over a 90 minute experiment for the two repeated baseline scans. (c) TAC’s of plasma from baseline study and blocking study (0.1 mg/kg of unlabeled letrozole co-administration) for the first two minutes (d) AUC of [11C-cyano]letrozole concentration in plasma over a 90 minute experiment at baseline and after letrozole treatment.